Search clinical trials for: Ipragliflozin (SGLT2 inhibitor)

Total 64325 results

Translational Research Center for Medical Innovation...
Astellas Pharma Inc; Osaka Saiseikai Nakatsu Hospital

Completed

Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II Diabetes (HARUKAS)

Diabetes Mellitus, Type 2

Japan
Kiyuk Chang
Seoul St. Mary's Hospital; Pusan National University Hospital; Korea University... and other collaborators

Recruiting

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients With Acute Myocardial Infarction, a Prospective, Multi-center Registry Study (RECORD-AMI)

Myocardial Infarction | Diabetes Mellitus, Type 2

Korea, Republic of
Jeil Pharmaceutical Co., Ltd.

Not yet recruiting

Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Compare the Oral Absorption of ASP1941 Among Two Types of Tablets

Healthy | Plasma Concentration of ASP1941

Japan
Astellas Pharma Inc

Completed

A Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941

Healthy | Pharmacokinetics of ASP1941

Japan
Samsung Medical Center

Not yet recruiting

The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction (ENRICH-PEF)

Heart Failure, Preserved Ejection Fraction

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus (BALANCE)

Type 2 Diabetes Mellitus

United States, Hungary, Poland, Romania, Italy, United Kingdom
Academisch Medisch Centrum - Universiteit van Amsterdam...
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

proMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2 (MERCURI-2)

Acute Kidney Injury | Cardiac Surgery | Sodium-Glucose Transporter 2 Inhibitor

Netherlands
Astellas Pharma Inc

Completed

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study of ASP1941 in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus

Japan
Astellas Pharma Inc
Astellas Pharma Taiwan, Inc.

Completed

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

Healthy | Pharmacokinetics of ASP1941

Taiwan
Astellas Pharma Inc

Completed

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

United States, India, Philippines, Colombia, Mexico
Astellas Pharma Korea, Inc.

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Type 2 Diabetes Mellitus

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

Japan
Sadat City University
Beni-Suef University

Completed

Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?

Diabete Type 2

Egypt
Astellas Pharma Inc

Completed

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients (STELLALONGTERM)

Type 2 Diabetes

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes Patients (STELLA-ELDER)

Type 2 Diabetes

Japan
Samsung Medical Center

Recruiting

Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention (PRESTIGE-AMI)

Heart Failure | Acute Myocardial Infarction

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Japan
Asan Medical Center
Samsung Medical Center; Astellas Pharma Korea, Inc.; Severance Hospital; Kyung...

Completed

Correlation Between Change of HbA1c, Urinary Glucose Excretion and Other Factors in Patients Treated With Ipragliflozin

Type 2 Diabetes Mellitus

Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients

Type II Diabetes Mellitus

Taiwan, Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
LMC Diabetes & Endocrinology Ltd.
Merck Sharp & Dohme LLC; Syreon Corporation

Withdrawn

Approaches To Therapy Escalation In T2D (ATTACC)

Type2 Diabetes
Astellas Pharma Inc

Terminated

A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

Taiwan, Korea, Republic of
University of Texas Southwestern Medical Center

Recruiting

Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4

Diabetes | Kidney Disease, Chronic

United States
Hamad Medical Corporation

Recruiting

Impact of Sodium-glucose Cotransporter 2 Inhibitors on Post-operative Atrial Fibrillation in Cardiothoracic Surgery

Atrial Fibrillation

Qatar
University of Minnesota

Recruiting

SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot

Acute Kidney Injury

United States
Jeil Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008

Healthy Adult

Korea, Republic of
Ewha Womans University Mokdong Hospital

Enrolling by invitation

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

Diabetes Mellitus, Type 2 | Atrial Fibrillation | SGLT-2 Inhibitor

Korea, Republic of
Dongying Zhang

Recruiting

Role of SGLT2I in Patients With Myocardial Infarction

Myocardial Infarction | Diabetes Mellitus

China
University of Palermo
Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello

Recruiting

SGLT-2 Inhibitors in the Treatment of Ascites

Cirrhosis, Liver | Ascites Hepatic | Diabete Type 2

Italy
University of Aarhus
Aarhus University Hospital

Recruiting

Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention (DAPAS)

Aortic Stenosis | Left Ventricle Hypertrophied

Denmark
University of Oxford

Completed

SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitis (SMASH)

Non-alcoholic Fatty Liver Disease

United Kingdom
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
Assiut University

Not yet recruiting

Gliflozins on HF in Regurgitant Rheumatic Heart

Heart Failure | Rheumatic Heart Disease
Nanjing First Hospital, Nanjing Medical University

Unknown

Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin

Type2 Diabetes
Queen's University, Belfast
Belfast Health and Social Care Trust

Recruiting

Investigation of Biomarker Response to SGLT2 Inhibition in Heart Failure (SiN-HF)

Heart Failure

United Kingdom
Astellas Pharma Inc

Completed

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Japan
University of Chicago

Recruiting

HF Patients With LVADs Being Treated With SGLT2i

Heart Failure With Reduced Ejection Fraction

United States
Theracos

Completed

Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of EGT0001474 in Healthy Volunteers

Safety and Tolerability of EGT0001474 in Healthy Volunteers

United States
University of Michigan
University of Colorado, Denver; Renal Pre-Competitive Consortium (RPC3)

Recruiting

Renal Mechanism of SGLT2 Inhibition

Diabetic Kidney Disease | Type 2 Diabetes

United States
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin (IMPRESSION)

Type 2 Diabetes Mellitus

Russian Federation
Assiut University

Not yet recruiting

Using of SGLt2 Inhibitors in Patients With Type 2 DM

Type 2 Diabetes
Zealand University Hospital

Not yet recruiting

Treatment With SGLT-2 Inhibitor for Postoperative Hyperglycemia in Acute Abdominal Surgery - a Randomized Trial

Stress Hyperglycemia | Postoperative Hyperglycemia
West China Hospital

Not yet recruiting

Ameliorating Metabolic Profiling After Kidney Transplantation (AMPKT)

Kidney Transplantation | Metabolic Disorder | Metformin | Empagliflozin

3

Subscribe